Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Zanni

Showing results (111-120 of 147) with videos related to

Pageof 15
Sort By:
Circulation. Heart Failure|December 29, 2025
Heart Failure Risk and Events in People With HIV: The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)Gerald S Bloomfield, Maya Watanabe, Sara McCallum, et al.
The Lancet. HIV|January 20, 2025
Performance of the pooled cohort equations and D:A:D risk scores among individuals with HIV in a global cardiovascular disease prevention trial: a cohort study leveraging data from REPRIEVESteven K Grinspoon, Markella V Zanni, Virginia A Triant, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2024
Pitavastatin Is Well-Tolerated With no Detrimental Effects on Physical FunctionKristine M Erlandson, Triin Umbleja, Heather J Ribaudo, et al.
AIDS (London, England)|June 18, 2025
No evidence of a detrimental effect of pitavastatin on neurocognitive function among people with HIVKristine M Erlandson, Ashley McKhann, Douglas W Kitch, et al.
The Lancet. HIV|April 3, 2025
Statin effects on the incidence of major non-cardiovascular disease events among a global cohort of people with HIV: a randomised controlled trialMarissa R Diggs, Triin Umbleja, Sara McCallum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2022
Geographical Differences in the Self-Reported Functional Impairment of People With Human Immunodeficiency Virus (HIV) and Associations With Cardiometabolic RiskKristine M Erlandson, Kathleen V Fitch, Sara A McCallum, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 27, 2023
Associations of Muscle Density and Area With Coronary Artery Plaque and Physical FunctionKristine M Erlandson, Triin Umbleja, Michael T Lu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2022
Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV)Samuel R Schnittman, Michael T Lu, Thomas Mayrhofer, et al.
AIDS (London, England)|May 27, 2025
Risks for sudden cardiac and undetermined cause of death among people with HIV in the REPRIEVE primary cardiovascular prevention trialChristopher deFilippi, Aya Awwad, Gerald S Bloomfield, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 5, 2024
Cytomegalovirus IgG is Associated With Physical Function But Not Muscle Density in People With HIVMaheen Z Abidi, Triin Umbleja, Edgar T Overton, et al.
Pageof 15

Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
Circulation. Heart Failure|December 29, 2025
Heart Failure Risk and Events in People With HIV: The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)Gerald S Bloomfield, Maya Watanabe, Sara McCallum, et al.
The Lancet. HIV|January 20, 2025
Performance of the pooled cohort equations and D:A:D risk scores among individuals with HIV in a global cardiovascular disease prevention trial: a cohort study leveraging data from REPRIEVESteven K Grinspoon, Markella V Zanni, Virginia A Triant, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2024
Pitavastatin Is Well-Tolerated With no Detrimental Effects on Physical FunctionKristine M Erlandson, Triin Umbleja, Heather J Ribaudo, et al.
AIDS (London, England)|June 18, 2025
No evidence of a detrimental effect of pitavastatin on neurocognitive function among people with HIVKristine M Erlandson, Ashley McKhann, Douglas W Kitch, et al.
The Lancet. HIV|April 3, 2025
Statin effects on the incidence of major non-cardiovascular disease events among a global cohort of people with HIV: a randomised controlled trialMarissa R Diggs, Triin Umbleja, Sara McCallum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2022
Geographical Differences in the Self-Reported Functional Impairment of People With Human Immunodeficiency Virus (HIV) and Associations With Cardiometabolic RiskKristine M Erlandson, Kathleen V Fitch, Sara A McCallum, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 27, 2023
Associations of Muscle Density and Area With Coronary Artery Plaque and Physical FunctionKristine M Erlandson, Triin Umbleja, Michael T Lu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2022
Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV)Samuel R Schnittman, Michael T Lu, Thomas Mayrhofer, et al.
AIDS (London, England)|May 27, 2025
Risks for sudden cardiac and undetermined cause of death among people with HIV in the REPRIEVE primary cardiovascular prevention trialChristopher deFilippi, Aya Awwad, Gerald S Bloomfield, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 5, 2024
Cytomegalovirus IgG is Associated With Physical Function But Not Muscle Density in People With HIVMaheen Z Abidi, Triin Umbleja, Edgar T Overton, et al.
Pageof 15